Axogen Corporation
12
1
4
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
33.3%
4 terminated/withdrawn out of 12 trials
50.0%
-36.5% vs industry average
17%
2 trials in Phase 3/4
75%
3 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction
Role: lead
Axoguard HA Plus Nerve Protector to Reduce Post-operative Neck and Shoulder Dysfunction in Patients Undergoing Neck Dissection
Role: collaborator
Nerve Protection Evaluation: Revision Cubital Tunnel Syndrome Decompression
Role: lead
Registry of Avive® Soft Tissue Membrane Utilization in Selected Applications of Acute Trauma of the Upper Extremity
Role: lead
Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends
Role: lead
Sensory Restoration After DIEP Flap Neurotization
Role: collaborator
Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain
Role: lead
Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer
Role: lead
Surgical Treatment of Chronic Neuropathic Pain
Role: lead
Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair
Role: lead
A Comparative Post-marketing Study of Commercially Available Peripheral Nerve Gap Repair Options
Role: lead
Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy
Role: collaborator
All 12 trials loaded